The only current objective study of executive compensation in the industry, providing a detailed picture of compensation packages at 224 publicly traded biotech companies.
Published by the editors of BioWorld Today, the newspaper of record for the biotechnology industry, the new BioWorld Executive Compensation Report 2009 provides you with a variety of perspectives on compensation issues by means of key statistics and graphic analyses.
You can review this product for 30 days. If you cancel within 30 days of receipt, you will receive a full credit upon return of the product together with a request for cancellation.
